Dronedarone in Pacemaker Patients With Paroxysmal Atrial Fibrillation.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Dronedarone (Primary)
- Indications Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- Acronyms DROPPAF
- 05 Apr 2012 European Clinical Trials Database reports actual initiation date as 2 Jul 2010.
- 28 Mar 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
- 24 Feb 2010 New trial record